Mobile App Logging for Diabetes in Pregnancy
Carolyn Zahler-Miller · NCT06005987
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 18–100 · Women only
- Healthy volunteers
- Accepted
- Study type
- Interventional · Not applicable
- Target enrollment
- 40
- US sites recruiting
- 1
- Study start
- June 1, 2024
- Record last updated
- January 31, 2025
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
To determine the effect of using a mobile app versus paper logs on compliance and percentage in range blood sugars in monitoring blood sugar in pregnant women with diabetes.
Being studied: OneTouch Reveal application
Conditions: Gestational Diabetes Mellitus in Pregnancy; Type 2 Diabetes
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- 18 years and older
- Verified intrauterine pregnancy
- At least 12 weeks gestation
- Diagnosed with either type 2 diabetes mellitus or gestational diabetes mellitus.
Exclusion Criteria
- Patients with less than 4 weeks anticipated to be remaining in pregnancy
- Pre-existing use of a continuous glucose monitor or other mobile application for glucose tracking
- Type 1 diabetes mellitus
- Non-English speaking patients
Recruiting US locations
Augusta University
Augusta, GA 30912
Site contact: Carolyn M Zahler-Miller · 706-721-2542 · czahlermiller@augusta.edu
Study contacts (from the official record)
- Rebecca Keipper, MD · 7067212541 · rkeipper@augusta.edu
- Carolyn M Zahler-Miller, MD · 7067212543 · czahlermiller@augusta.edu
Similar studies in Georgia
All diabetes studies in Georgia →- RecruitingHealthy volunteersEarly Phase 1
Type 1 Diabetes, Endothelin, and Skeletal Muscle Mitochondrial Dysfunction: The Role of Sirtuin-1
Augusta University
- Location
- Augusta, GA
- Eligibility basics
- Ages 18+
- RecruitingHealthy volunteersPhase 3
A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)
Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics
- Location
- Atlanta, GA + 55 other US sites
- Eligibility basics
- Ages 18–79
- RecruitingHealthy volunteers
A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events
Cleerly, Inc.
- Location
- Augusta, GA + 121 other US sites
- Eligibility basics
- Ages 55+
- Recruiting
SPYRAL GEMINI Pilot Study
Medtronic Vascular
- Location
- Atlanta, GA + 11 other US sites
- Eligibility basics
- Ages 18–80